4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Adenocarcinoma of Lung in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Alam, N; Iqbal, S; Islam, M; Najnin, H; Zaidi, R | 1 |
Bakkenist, CJ; Bao, R; Burns, TF; Dacic, S; Devadassan, P; Gaither-Davis, A; Huang, EH; Kumar, V; Stabile, LP; Steinman, RA; Vendetti, FP | 1 |
Hou, R; Ma, X; Qu, Z; Yu, J; Zhang, L; Zhang, W; Zhuang, C | 1 |
Davies, G; Ehli, E; Ezzeddine, D; Fowler, J; Fujimoto, J; Fukuoka, J; Jakubek, Y; Kadara, H; Kapere Ochieng, J; Lang, W; Liu, Y; McDowell, T; Nunomura-Nakamura, S; Petersen, J; Scheet, P; Wistuba, II | 1 |
Ebi, H; Jenkins, BJ; McLeod, L; Rose-John, S; Ruwanpura, S; Saad, MI; Sagi, I; Yu, L | 1 |
Imaida, K; Kinouch, S; Kishi, S; Nakano, Y; Ninomiya, F; Saoo, K; Tanizawa, J; Yamakawa, K; Yokohira, M | 1 |
Iyama, S; Kano, J; Kim, Y; Morishita, Y; Noguchi, M; Sakashita, S; Satomi, K; Shiba-Ishii, A; Shiozawa, T | 1 |
Biddick, L; Kopelovich, L; Kumar, G; Lightfoot, S; Madka, V; Mohammed, A; Patlolla, JM; Qian, L; Rao, CV; Sadeghi, M; Zhang, Y | 1 |
Imaida, K; Kanie, S; Kishi, S; Nakano, Y; Yamakawa, K; Yokohira, M | 1 |
Hecht, SS; Hermanson, D; Johnson, TE; Kassie, F; Lu, J; O'Sullivan, MG; Upadhyaya, P; Wang, L; Xing, C | 1 |
Kassie, F; Melkamu, T; Qian, X; Upadhyaya, P | 1 |
11 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Adenocarcinoma of Lung
Article | Year |
---|---|
Development of a Lung Cancer Model in Wistar Rat and In Silico Screening of its Biomarkers.
Topics: Adenocarcinoma of Lung; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Computer Simulation; Disease Models, Animal; Drug Design; ErbB Receptors; Lung Neoplasms; Male; Molecular Docking Simulation; Molecular Targeted Therapy; Nitrosamines; Rats; Rats, Wistar | 2021 |
Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.
Topics: Adenocarcinoma of Lung; Animals; B7-H1 Antigen; Carcinogens; Cell Line, Tumor; Female; Humans; Lung Neoplasms; Male; Mice; Mutation; Neoplasms, Experimental; Nicotiana; Nitrosamines; Smoke; Tumor Microenvironment | 2021 |
Exposure to a mixture of cigarette smoke carcinogens disturbs gut microbiota and influences metabolic homeostasis in A/J mice.
Topics: Adenocarcinoma of Lung; Animals; Bacteria; Benzo(a)pyrene; Carcinogens; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Lung; Lung Neoplasms; Metabolome; Metabolomics; Mice, Inbred Strains; Nitrosamines | 2021 |
Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Carcinogens; Cell Lineage; Genes, Tumor Suppressor; Humans; Lung Neoplasms; Mice; Mice, Knockout; Mutation; Nitrosamines; Proto-Oncogene Proteins p21(ras); Receptors, G-Protein-Coupled | 2017 |
The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis.
Topics: ADAM17 Protein; Adenocarcinoma of Lung; Animals; Carcinogenesis; Carcinogens; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Nitrosamines; Phosphorylation; Signal Transduction; Tobacco Smoke Pollution | 2020 |
Napsin A is possibly useful marker to predict the tumorigenic potential of lung bronchiolo-alveolar hyperplasia in F344 rats.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenoma; Animals; Aspartic Acid Endopeptidases; Biomarkers, Tumor; Bronchioles; Hyperplasia; Immunohistochemistry; Lung; Lung Neoplasms; Nitrosamines; Prognosis; Pulmonary Alveoli; Rats; Rats, Inbred F344 | 2014 |
Stratifin accelerates progression of lung adenocarcinoma at an early stage.
Topics: 14-3-3 Proteins; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Disease Progression; Exoribonucleases; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Transgenic; Neoplasm Metastasis; Neoplasm Staging; Nitrosamines; Xenograft Model Antitumor Assays | 2015 |
Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; bcl-X Protein; Carcinogens; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Nicotiana; Nicotine; Nitrosamines; Proliferating Cell Nuclear Antigen; Ribosomal Protein S6 Kinases, 90-kDa; Sirolimus; TOR Serine-Threonine Kinases | 2015 |
Activation of MEK1/2-ERK1/2 signaling during NNK-induced lung carcinogenesis in female A/J mice.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenoma; Animals; Cell Transformation, Neoplastic; Enzyme Activation; Female; Lung Neoplasms; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinase 2; MAP Kinase Signaling System; Mice, Inbred A; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Nitrosamines; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins p21(ras) | 2016 |
Lung tumorigenesis suppressing effects of a commercial kava extract and its selected compounds in A/J mice.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents, Phytogenic; Benzo(a)pyrene; Carcinogens; Cell Death; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Female; Kava; Liver; Lung Neoplasms; Mice; Mice, Inbred Strains; Nitrosamines; Phytotherapy; Plant Extracts | 2011 |
Indole-3-carbinol inhibited tobacco smoke carcinogen-induced lung adenocarcinoma in A/J mice when administered during the post-initiation or progression phase of lung tumorigenesis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anticarcinogenic Agents; Carcinogens; Cell Growth Processes; Cell Transformation, Neoplastic; Female; Humans; Indoles; Lung Neoplasms; Mice; Mice, Inbred A; Nitrosamines; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Receptor Protein-Tyrosine Kinases | 2011 |